Patents by Inventor Nicholas V. Perricone

Nicholas V. Perricone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210093592
    Abstract: The present invention generally relates to systems and methods for treating vitiligo. In one set of embodiments, the present invention comprises a composition comprising pyruvic acid and/or a pyruvate salt. The composition may be formulated for application to the skin of a subject, for instance, as a gel, lotion, cream, ointment, soap, or stick. In some cases, the composition may comprise a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present as a liquid crystal, and/or in liposomes, micelles, or other vesicles. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like.
    Type: Application
    Filed: May 20, 2020
    Publication date: April 1, 2021
    Applicant: Transdermal Biotechnology, Inc.
    Inventor: Nicholas V. Perricone
  • Patent number: 10895761
    Abstract: A laser protection eyewear lens includes a lens substrate comprising an embedded wavelength filter having a first filter function, and a multi-layer dielectric filter applied to at least one of an inside and an outside surface of the lens substrate that comprises a second filter function having at least one center wavelength and bandwidth. The first filter function of the embedded wavelength filter and the second filter function of the multilayer dielectric filter produce a combined filter function that attenuates light reflecting off the multi-layer dielectric filter.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: January 19, 2021
    Assignee: PerriQuest Defense Research Enterprises, LLC
    Inventors: Nicholas V. Perricone, Kristin A. Rauschenbach
  • Patent number: 10695306
    Abstract: The present invention generally relates to systems and methods for treating vitiligo. In one set of embodiments, the present invention comprises a composition comprising pyruvic acid and/or a pyruvate salt. The composition may be formulated for application to the skin of a subject, for instance, as a gel, lotion, cream, ointment, soap, or stick. In some cases, the composition may comprise a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present as a liquid crystal, and/or in liposomes, micelles, or other vesicles. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: June 30, 2020
    Assignee: Transdermal Biotechnology, Inc.
    Inventor: Nicholas V. Perricone
  • Publication number: 20190314306
    Abstract: The present invention generally relates to systems and methods for treating vitiligo. In one set of embodiments, the present invention comprises a composition comprising pyruvic acid and/or a pyruvate salt. The composition may be formulated for application to the skin of a subject, for instance, as a gel, lotion, cream, ointment, soap, or stick. In some cases, the composition may comprise a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present as a liquid crystal, and/or in liposomes, micelles, or other vesicles. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like.
    Type: Application
    Filed: April 23, 2019
    Publication date: October 17, 2019
    Applicant: Transdermal Biotechnology, Inc.
    Inventor: Nicholas V. Perricone
  • Patent number: 10388461
    Abstract: The present invention generally relates to arrangements for capacitors, for example, for energy storage and other applications. Certain aspects are generally directed to a plurality of capacitors, packed into various 2- and 3-dimensional arrays. The capacitors may have any suitable shape, including spherical and/or cylindrical. The capacitors may be packed into a variety of efficient arrangements, for example, face-centered cubic arrangements, hexagonal close packed arrangements, Barlow packing arrangements, or the like. In some cases, such capacitors may be packed with packing fractions of at least 55%, 60%, or more. Other embodiments of the present invention are generally directed to methods of making or using such capacitor arrangements, kits involving such capacitor arrangements, or the like.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: August 20, 2019
    Assignee: PerriQuest Defense Research Enterprises, LLC
    Inventor: Nicholas V. Perricone
  • Patent number: 10335450
    Abstract: The present invention generally relates to systems and methods for the transdermal delivery of the heptapeptide ZW1. In some aspects, ZW1 may be contained with a composition comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present in liposomes, micelles, liquid crystals, or other configurations. The composition can take the form of a gel, a cream, a lotion, an ointment, a solution, a solid “stick,” etc., that can be rubbed or sprayed onto the skin. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: July 2, 2019
    Assignee: Transdermal Biotechnology, Inc.
    Inventor: Nicholas V. Perricone
  • Publication number: 20190183819
    Abstract: The present invention generally relates to systems and methods for treating vitiligo and related conditions. In some embodiments, a composition comprising phloroglucinol and/or related compounds, such as benzenetriols, phlorotannins, or algae extract, is applied to the skin. The composition may be formulated for application to the skin of a subject, for instance, as a gel, lotion, cream, ointment, soap, or stick. The composition may also comprise a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present as a liquid crystal, and/or in liposomes, micelles, or other vesicles. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like.
    Type: Application
    Filed: December 6, 2018
    Publication date: June 20, 2019
    Applicant: Transdermal Biotechnology, Inc.
    Inventors: Nicholas V. Perricone, Peter T. Pugliese
  • Patent number: 10314800
    Abstract: The present invention generally relates to systems and methods for treating vitiligo. In one set of embodiments, the present invention comprises a composition comprising pyruvic acid and/or a pyruvate salt. The composition may be formulated for application to the skin of a subject, for instance, as a gel, lotion, cream, ointment, soap, or stick. In some cases, the composition may comprise a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present as a liquid crystal, and/or in liposomes, micelles, or other vesicles. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: June 11, 2019
    Assignee: Transdermal Biotechnology, Inc.
    Inventor: Nicholas V. Perricone
  • Patent number: 10226511
    Abstract: The present invention generally relates to compositions and methods for topical or transdermal delivery, including treatment and prevention of learning and memory disorders, and enhancement of learning or memory. In some cases, the composition may include nitric oxide and/or peptides such as thyrotropin-releasing hormone (TRH) and/or GnRH (gonadotropin-releasing hormone). The nitric oxide and/or peptide may be present within a first phase comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present in liposomes, micelles, or other structures containing nitric oxide and/or peptide. The composition can take the form of a gel, a cream, a lotion, an ointment, a solution, a solid “stick,” etc., that can be rubbed or sprayed onto the skin. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: March 12, 2019
    Assignee: Transdermal Biotechnology, Inc.
    Inventor: Nicholas V. Perricone
  • Patent number: 10213457
    Abstract: The present invention generally relates to compositions and methods for treatment of subjects in need of muscle growth, muscle repair, improved muscular and neuromuscular control, and treatments for neuromuscular and neurological disorders, including brain disorders. In some cases, the composition may include nitric oxide and/or peptides. The nitric oxide and/or peptides may be present within a first phase comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present in liposomes, micelles, or other vesicles containing nitric oxide and/or peptide. The composition can take the form of a gel, a cream, a lotion, an ointment, a solution, a solid “stick,” etc., that can be rubbed or sprayed onto the skin, e.g., onto a location where muscle growth, muscle repair, or improved muscular and neuromuscular control is desired, or on another suitable portion of the skin.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: February 26, 2019
    Assignee: Transdermal Biotechnology, Inc.
    Inventor: Nicholas V. Perricone
  • Publication number: 20190046561
    Abstract: Embodiments described herein generally relate to articles and methods for containing compositions comprising hydrogen gas. In some embodiments, the article comprises a container that comprises glass. In some cases, the container may further comprise TiO2, which may be embedded within the glass, coated on the glass, etc. The container further may contain a composition within the container. In some cases, the composition may comprise dissolved hydrogen gas. Such compositions may be useful, for example, for the treatment of animal and human diseases, for improvement in athletic performance, for the enhancement of the overall health of a subject, or the like.
    Type: Application
    Filed: August 8, 2017
    Publication date: February 14, 2019
    Applicant: Perricone Hydrogen Water Company, LLC
    Inventor: Nicholas V. Perricone
  • Publication number: 20190047729
    Abstract: Embodiments described herein generally relate to methods and systems for preparing compositions, such as those comprising hydrogen gas. In some embodiments, the method comprises injecting liquid hydrogen and/or a liquid noble gas(es) into another liquid (e.g., a composition) such that at least a portion of the liquid hydrogen and/or liquid noble gas(es) can change phase into a gaseous phase. The liquid noble gas may be, for example, liquid xenon, liquid argon, or the like. In some embodiments, the gaseous hydrogen and/or the liquid noble gas(es) may infuse with the composition (e.g., such that at least a portion of the hydrogen gas and/or noble gas(es) is dissolved within the composition). Such compositions comprising hydrogen gas and/or noble gas(es) may be useful, for example, for the treatment of animal and human diseases, for improvement in athletic performance, for the enhancement of the overall health of a subject, or the like. Such compositions and/or liquids described herein may be administered (e.g.
    Type: Application
    Filed: August 8, 2017
    Publication date: February 14, 2019
    Applicant: Perricone Hydrogen Water Company, LLC
    Inventor: Nicholas V. Perricone
  • Publication number: 20190046755
    Abstract: Embodiments described herein generally relate to articles and methods for containing compositions comprising hydrogen gas. According to some embodiments, the article comprises a container that comprises metal, and an epoxy. The epoxy may at least partially coating a surface of the metal. The container may further contain a liquid or other material, which may comprise dissolved hydrogen gas. Such compositions may be useful, for example, for the treatment of animal and human diseases, for improvement in athletic performance, for the enhancement of the overall health of a subject, or the like.
    Type: Application
    Filed: December 8, 2017
    Publication date: February 14, 2019
    Applicant: Perricone Hydrogen Water Company, LLC
    Inventor: Nicholas V. Perricone
  • Publication number: 20190046562
    Abstract: Embodiments described herein generally relate to medicinal compositions (e.g., compositions comprising an active pharmaceutical agent) such as those comprising liquid hydrogen and/or hydrogen gas. In certain embodiments, the composition comprises hydrogen and/or noble gas(es) in a medicinal composition, for example, within the aqueous phase (e.g., dissolved). For example, in some cases, the medicinal composition may comprise an active pharmaceutical ingredient and hydrogen (H2) and/or noble gas(es). The noble gas may be, for example, xenon, argon, or the like. In some embodiments, the hydrogen and/or the noble gas(es) may infuse with the composition (e.g., such that at least a portion of the hydrogen gas and/or noble gas(es) is dissolved within the composition). Such compositions comprising hydrogen gas and/or noble gas(es) may be useful, for example, for the treatment of animal and human diseases, for improvement in athletic performance, for the enhancement of the overall health of a subject, or the like.
    Type: Application
    Filed: August 8, 2017
    Publication date: February 14, 2019
    Applicant: Perricone Hydrogen Water Company, LLC
    Inventor: Nicholas V. Perricone
  • Publication number: 20190046754
    Abstract: Embodiments described herein generally relate to articles and methods for containing compositions comprising hydrogen gas. According to some embodiments, the article comprises a container that comprises metal, and an epoxy. The epoxy may at least partially coating a surface of the metal. The container may further contain a liquid or other material, which may comprise dissolved hydrogen gas. Such compositions may be useful, for example, for the treatment of animal and human diseases, for improvement in athletic performance, for the enhancement of the overall health of a subject, or the like.
    Type: Application
    Filed: August 8, 2017
    Publication date: February 14, 2019
    Applicant: Perricone Hydrogen Water Company, LLC
    Inventor: Nicholas V. Perricone
  • Publication number: 20190043670
    Abstract: The present invention generally relates to arrangements for capacitors, for example, for energy storage and other applications. Certain aspects are generally directed to a plurality of capacitors, packed into various 2- and 3-dimensional arrays. The capacitors may have any suitable shape, including spherical and/or cylindrical. The capacitors may be packed into a variety of efficient arrangements, for example, face-centered cubic arrangements, hexagonal close packed arrangements, Barlow packing arrangements, or the like. In some cases, such capacitors may be packed with packing fractions of at least 55%, 60%, or more. Other embodiments of the present invention are generally directed to methods of making or using such capacitor arrangements, kits involving such capacitor arrangements, or the like.
    Type: Application
    Filed: August 2, 2017
    Publication date: February 7, 2019
    Inventor: Nicholas V. Perricone
  • Patent number: 10188603
    Abstract: The present invention generally relates to compositions and methods for topical or transdermal delivery, and treatment of sexual dysfunction. The compositions can be used in a variety of applications, including treating erectile dysfunction or sexual dysfunction. In some cases, the composition may include nitric oxide and/or peptides. The nitric oxide and/or peptide may be present within a first phase comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present in liposomes, micelles, or other vesicles containing nitric oxide, peptides, or both. The composition can take the form of a gel, a cream, a lotion, an ointment, a solution, a solid “stick,” etc., that can be rubbed or sprayed onto the skin, e.g., onto the penis, vulva, or other suitable portion of the skin. The composition can also be applied to a mucosal surface in some instances.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: January 29, 2019
    Assignee: Transdermal Biotechnology, Inc.
    Inventor: Nicholas V. Perricone
  • Patent number: 10155048
    Abstract: The present invention generally relates to compositions and methods for treatment of subjects having or at risk of cancer or other conditions. In some cases, the composition may include nitric oxide and/or peptides. The nitric oxide and/or peptide may be present within a first phase comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present in liposomes, micelles, or other vesicles containing nitric oxide. The composition can take the form of a gel, a cream, a lotion, an ointment, a solution, a solid “stick,” etc., that can be rubbed or sprayed onto the skin. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: December 18, 2018
    Assignee: Transdermal Biotechnology, Inc.
    Inventor: Nicholas V. Perricone
  • Patent number: 10155010
    Abstract: Embodiments described herein generally relate to articles and methods for containing compositions comprising hydrogen gas. In some embodiments, the article comprises a container that comprises glass. In some cases, the container may further comprise TiO2, which may be embedded within the glass, coated on the glass, etc. The container further may contain a composition within the container. In some cases, the composition may comprise dissolved hydrogen gas. Such compositions may be useful, for example, for the treatment of animal and human diseases, for improvement in athletic performance, for the enhancement of the overall health of a subject, or the like.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: December 18, 2018
    Assignee: Perricone Hydrogen Water Company, LLC
    Inventor: Nicholas V. Perricone
  • Publication number: 20180338995
    Abstract: Embodiments described herein generally relate to systems and methods for treatments using xenon and hydrogen. In some embodiments, liquids comprising xenon and hydrogen are provided. Such liquids may be useful, for example, for the treatment of animal and human diseases, for improvement in athletic performance, for the enhancement of the overall health of a subject, or the like. The liquids (e.g., aqueous solutions) and articles described herein may be administered to a subject, e.g., drunk by a subject. Some embodiments relate to liquids disposed within a container (e.g., a sealed container), such that the liquid comprises hydrogen gas and a noble gas dissolved or otherwise contained (e.g., infused) in the liquid. In certain embodiments, the hydrogen gas and/or noble gas may be present in the liquid at a particular concentration (e.g., a physiologically relevant concentration).
    Type: Application
    Filed: May 23, 2018
    Publication date: November 29, 2018
    Applicant: Perricone Hydrogen Water Company, LLC
    Inventor: Nicholas V. Perricone